PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
7830265-1	1995	A series of 5-aryl-2,3-dihydroimidazo[2,1-a]isoquinolines previously reported to be platelet activating factor (PAF) receptor antagonists were evaluated for potential antitumor activity.	5-aryl-2,3-dihydroimidazo[2,1-a]isoquinolines	12-57	platelet activating factor receptor	Homo sapiens	84-125